Related Articles
Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis
Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis
Cyclin B1 expression as an independent prognostic factor for lung adenocarcinoma and its potential pathways
Anti‑malarial drug dihydroartemisinin downregulates the expression levels of <em>CDK1</em> and <em>CCNB1</em> in liver cancer
AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma